Kotra Industries Bhd
KLSE:KOTRA
Kotra Industries Bhd
Net Income (Common)
Kotra Industries Bhd
Net Income (Common) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
K
|
Kotra Industries Bhd
KLSE:KOTRA
|
Net Income (Common)
myr40m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
9%
|
CAGR 10-Years
17%
|
|
|
P
|
PeterLabs Holdings Bhd
KLSE:PLABS
|
Net Income (Common)
myr2.8m
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-1%
|
|
|
A
|
Apex Healthcare Bhd
KLSE:AHEALTH
|
Net Income (Common)
myr76.5m
|
CAGR 3-Years
9%
|
CAGR 5-Years
8%
|
CAGR 10-Years
9%
|
|
|
R
|
Rhone Ma Holdings Bhd
KLSE:RHONEMA
|
Net Income (Common)
myr12.3m
|
CAGR 3-Years
3%
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
|
|
Y
|
YSP Southeast Asia Holding Bhd
KLSE:YSPSAH
|
Net Income (Common)
myr26.7m
|
CAGR 3-Years
21%
|
CAGR 5-Years
3%
|
CAGR 10-Years
5%
|
|
|
D
|
Duopharma Biotech Bhd
KLSE:DPHARMA
|
Net Income (Common)
myr56.1m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
6%
|
|
Kotra Industries Bhd
Glance View
Kotra Industries Bhd.is an investment holding company, which engages in the manufacturing and trading of pharmaceutical and healthcare products. The company is headquartered in Malacca, Melaka and currently employs 660 full-time employees. The company went IPO on 2000-10-30. The Company, through its subsidiary, Kotra Pharma (M) Sdn. Bhd, is engaged in pharmaceutical and healthcare products manufacturing and trading business. Its segments include Malaysia, Asia and Africa. Its products include Appeton Multivitamin Pastilles, which is a healthy chewable pastille (non-sugar coated) for children; Axcel Glimepiride Medication, which is used to treat diabetes mellitus type 2; Axcel Bromhexine (Children) Syrup, which is a mucolytic medicine used in the treatment of respiratory chest congestion; Arite Beclometasone 50mcg (Metered Dose Inhaler Product), which is used in long-term management of asthma; Vaxcel Granisetron Injection, which is an antiemetic to treat nausea and vomiting following chemotherapy and radiotherapy, and Axcel Atenolol, which is used to treat high blood pressure and heart-associated chest pain.
See Also
What is Kotra Industries Bhd's Net Income (Common)?
Net Income (Common)
40m
MYR
Based on the financial report for Dec 31, 2024, Kotra Industries Bhd's Net Income (Common) amounts to 40m MYR.
What is Kotra Industries Bhd's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
17%
Over the last year, the Net Income (Common) growth was -28%. The average annual Net Income (Common) growth rates for Kotra Industries Bhd have been -6% over the past three years , 9% over the past five years , and 17% over the past ten years .
You don't have any saved screeners yet